Another high-tech innovator is set to leave California this year as Cargo Therapeutics confirmed on March 18 that it is winding down operations.
The biotechnology company was developing “next-generation cell therapy cures” for cancer patients, one of which was designed to address several known causes of cancer relapse in patients, according to Cargo Therapeutics.